Pacira Receives European Commission Approval for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical PainGlobeNewsWire • 11/18/20
Pacira BioSciences Reports Preliminary Net Product Sales of $41.7 Million for October 2020GlobeNewsWire • 11/11/20
Pacira BioSciences to Present at the 2020 Jefferies Virtual London Healthcare ConferenceGlobeNewsWire • 11/10/20
Flexion Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare ConferenceGlobeNewsWire • 11/05/20
Flexion Therapeutics (FLXN) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/04/20
Flexion Therapeutics Reports Third-Quarter 2020 Financial Results and Recent Business HighlightsGlobeNewsWire • 11/04/20
Flexion Therapeutics to Report Third-Quarter 2020 Financial Results on November 4, 2020GlobeNewsWire • 10/29/20
Pacira BioSciences, Inc. (PCRX) CEO David Stack on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 10/29/20
Flexion Therapeutics (FLXN) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseZacks Investment Research • 10/29/20
Pacira BioSciences Reports Third Quarter 2020 Financial Results and Business UpdateGlobeNewsWire • 10/29/20
Pacira Launches State-of-the-Art Training Center Dedicated to Advancing Best Practice Regional Approaches to Manage Acute PainGlobeNewsWire • 10/21/20
Pacira to Report Third Quarter 2020 Financial Results on Thursday October 29, 2020GlobeNewsWire • 10/20/20
Is Pacira BioSciences (PCRX) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 10/19/20
Flexion Therapeutics Announces Preliminary Third-Quarter 2020 ZILRETTA® Net Sales of Approximately $23.6 MillionGlobeNewsWire • 10/13/20
Flexion Therapeutics to Present at the 2020 Cell & Gene Virtual Meeting on the MesaGlobeNewsWire • 10/08/20
Pacira BioSciences Reports Preliminary Net Product Sales of $116.9 Million for the Third Quarter of 2020GlobeNewsWire • 10/07/20
Pacira Receives Positive CHMP Opinion for EXPAREL® (bupivacaine liposome injectable suspension) for the Treatment of Postsurgical PainGlobeNewsWire • 09/18/20
IPG and Pacira BioSciences Announce Collaboration to Reduce Postsurgical Opioid Prescribing and Surgical Procedure CostsGlobeNewsWire • 09/15/20
Pacira BioSciences to Present at the 2020 H.C. Wainwright 22nd Annual Global Investment ConferenceGlobeNewsWire • 09/11/20
Flexion Therapeutics to Present at the H.C. Wainwright Virtual Healthcare ConferenceGlobeNewsWire • 09/09/20